Cargando…
PEPT1 is essential for the growth of pancreatic cancer cells: a viable drug target
PEPT1 is a proton-coupled peptide transporter that is up-regulated in PDAC cell lines and PDXs, with little expression in the normal pancreas. However, the relevance of this up-regulation to cancer progression and the mechanism of up-regulation have not been investigated. Herein, we show that PEPT1...
Autores principales: | Schniers, Bradley K., Rajasekaran, Devaraja, Korac, Ksenija, Sniegowski, Tyler, Ganapathy, Vadivel, Bhutia, Yangzom D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589330/ https://www.ncbi.nlm.nih.gov/pubmed/34569600 http://dx.doi.org/10.1042/BCJ20210377 |
Ejemplares similares
-
Deletion of Slc6a14 reduces cancer growth and metastatic spread and improves survival in KPC mouse model of spontaneous pancreatic cancer
por: Schniers, Bradley K., et al.
Publicado: (2022) -
Carbidopa, an activator of aryl hydrocarbon receptor, suppresses IDO1 expression in pancreatic cancer and decreases tumor growth
por: Korac, Ksenija, et al.
Publicado: (2022) -
SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer
por: Sniegowski, Tyler, et al.
Publicado: (2021) -
Amino acid transporter SLC38A5 is a tumor promoter and a novel therapeutic target for pancreatic cancer
por: Sniegowski, Tyler, et al.
Publicado: (2023) -
Chronic exposure to excess iron promotes EMT and cancer via p53 loss in pancreatic cancer
por: Bhutia, Yangzom D., et al.
Publicado: (2020)